# The Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015, Paragraph 9

Extent: E+W+S

A liquid formulation—
(a) containing a botanical extract of cannabis—
(i) with a concentration of not more than 30 milligrams of cannabidiol per millilitre, and not more than 30 milligrams of delta-9-tetrahydrocannabinol per millilitre, and
(ii) where the ratio of cannabidiol to delta-9-tetrahydrocannabinol is between 0.7 and 1.3,
(b) which is dispensed through a metered dose pump as a mucosal mouth spray, and
(c) which was approved for marketing by the Medicines and Healthcare Products Regulatory Agency on the 16th June 2010.

---
Source: https://www.legislation.gov.uk/uksi/2015/704/schedule/1/paragraph/9 (the official version)
Page: https://openlegislation.uk/misuse-of-drugs-designation-england-wales-and-scotland-order-2015/schedule-1/paragraph-9
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

